Stock closed lower on Friday, with the Dow losing ground in afternoon trading after the White House said President Trump will implement on Saturday tariffs of 25% on Canadian and Mexican imports and 10% on Chinese goods with immediate effect.

The Fed's preferred inflation gauge, the personal consumption and expenditures index, rose 0.3% from November and 2.6% on an annual basis.

Stock futures are higher Friday morning as investors respond to a steady stream of earnings reports and await the release of a closely followed inflation indicator.

Dow said on Thursday it will lay off 1,500 employees as part of its $1 billion cost savings plan due to lackluster demand and margin pressures, causing its shares to drop 6.3% in morning trade.

Stock futures are mixed Thursday morning as investors react to a barrage of earnings reports from major companies and important economic indicators.

P&G is a unique Dividend King because it uses both buybacks and dividends to return capital to shareholders. A Dividend King like Coca-Cola may yield more than P&G, but it doesn't consistently buy back stock.

Midland-based Dow is eliminating 1,500 jobs around the world as part of a plan to cut $1 billion worth of spending.

Fundamental company data and analyst estimates provided ... Diaries table for 4 p.m. closing data. Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity ...

Eight of the 30 Dow components lost value in 2024. Here's a quick look at each company, to help you determine which dividend stocks stand out as the best buys right now.

Dow Jones continues its attempts to settle above the resistance at 44,900 – 45,000 as IBM gains 12.2%. The stock tested historic highs after beating analyst estimates on both earnings and revenue.

S&P 500 futures rise as Meta and Tesla gain, but Microsoft and Caterpillar drag the Dow. US stock market reacts to earnings, GDP data, and Fed outlook.

Good news about an experimental weight-loss shot sent shares in Ozempic maker Novo Nordisk soaring, making it once again Europe's most-valuable listed company. A pullback in the Danish drug maker's shares had meant it recently ceded that title to French luxury conglomerate LVMH.